Artículos de revistas
Nausea, Vomiting And Quality Of Life Of Patients With Cancer Undergoing Antineoplastic Treatment: An Evaluation By Pharmacists.
Registro en:
The International Journal Of Pharmacy Practice. , 2015-Jan.
2042-7174
10.1111/ijpp.12169
25572714
Autor
de Souza, Cinthia Madeira
Visacri, Marília Berlofa
Ferrari, Graziele Baldan
Tuan, Bruna Taliani
Costa, Anna Paula Lourenço
Barbosa, Cristina Rosa
Lima, Carmen Silvia P
Mazzola, Priscila Gava
Moriel, Patrícia
Institución
Resumen
This study aims to evaluate the frequency and severity of nausea and vomiting using two different instruments and relate them to quality of life (QOL) in patients with cancer receiving antineoplastic treatment. Severity of chemotherapy-induced nausea and vomiting (CINV) was measured by Common Terminology Criteria for Adverse Events (CTCAE) and a numerical scale. QOL was assessed using the Functional Assessment of Cancer Therapy-General questionnaire. Of the 50 patients studied, 60.0% reported nausea (40.0% CTCAE grade 1; 66.7% moderate intensity on numerical scale) and 30.0% reported vomiting (46.7% CTCAE grades 1 and 2, each; 66.7% moderate intensity on numerical scale). CINV did not influence overall QOL. The frequency of CINV was high. There was no association between nausea/vomiting and overall QOL.